Patent · US Active

Crystalline form of 5(S)-(2-hydroxyethoxy)-20(S)-camptothecin

US7601732B2 · kind B2 · utility

1Cited by
1References
36Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 24, 2007
Grant dateOct 13, 2009
Priority date
Expiry dateMay 24, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

A crystalline form of 5(S)-(2′-hydroxyethoxy)-20(S)-camptothecin diastereoisomer of 5(RS)-(2′-hydroxyethoxy)-20(S)-camptothecin is described that is characterized by having an X-ray powder diffraction pattern comprising one or more peak intensities expressed in degrees 2θ that are selected from the group consisting of 7.2±0.1, 9.4±0.1, 11.02±0.1, 12.00±0.1, 14.54±0.1, 15.2±0.1, 18.92±0.1, 21.86±0.1, 22.74±0.1 and 26.42±0.1. Methods of making and using the compound are also described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.